Biological Information | |
---|---|
Background Information: | STK39 (Serine/Threonine Kinase 39), also known as SPAK (Ste20-related Proline Alanine-rich Kinase), is a serine/threonine protein kinase that is involved in the regulation of ion transport and cell volume in response to changes in osmolarity. STK39 phosphorylates and activates several ion transporters and channels, including the sodium-potassium-chloride cotransporter (NKCC1) and the potassium chloride cotransporter (KCC2), and it has been suggested to play a role in the regulation of blood pressure and salt-sensitive hypertension.
Research has also suggested that STK39 may play a role in the regulation of other cellular processes, including cell proliferation, cell cycle progression, and apoptosis. Additionally, STK39 has been implicated in several diseases, including hypertension, diabetes, and cancer, and efforts to develop small-molecule inhibitors of the kinase are underway as potential therapies for these conditions. |
Target Class: | Kinase |
Accession Number: | NM_013233.1; NM_016289.2 |
Target Name: | STK39 |
Target Species: | Human |
Usage | |
Product Type: | Enzymes |
Application: | Drug Discovery & Development |
Storage Conditions: | 1 year at -70°C |
Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
STK39, active
Datasheets
16-049x Datasheet
View Document